Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 484 results for "Zohydro"

Pernix Therapeutics Holdings unveils new formulation of Zohydr...

Pharmaceutical company Pernix Therapeutics Holdings According to Pernix Therapeutics, Zohydro ER with BeadTek is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which ... Bloomberg, 2 weeks ago

1 images for "Zohydro"

Citybizlist, 3 weeks ago

Pernix Introduces Zohydro ER with BeadTek

Pernix Therapeutics Holdings, a specialty pharmaceutical company, reported that the new formulation of Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, CII, with BeadTek is now available in U.S. pharmacies. According to a release, on ...
 Individual.com2 weeks ago New Zohydro ER Formulation with Abuse-Deterrent Technology Launched  Monthly Prescribing Reference2 weeks ago Pernix Launches Zohydro┬« ER with BeadTek  World Energy Source2 weeks ago PERNIX THERAPEUTICS : Releases Pharmacokinetic Data for ZX007 Third Generation Zohydro ER on Track  4 Traders2 weeks ago

Pernix Therapeutics Purchases Zohydro ER Franchise

Pernix Therapeutics Holdings reported that it has closed its acquisition of the Zohydro ER (hydrocodone bitartrate) franchise, comprising three extended release hydrocodone products, including an abuse-deterrent pipeline and all related intellectual ...
 Individual.com3 weeks ago
Canadian Business Journal

Zogenix Closes Sale of Zohydro(R) ER Business to Pernix

(GLOBE NEWSWIRE) -- Zogenix, Inc. ( Nasdaq:ZGNX ), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, announced today that it has closed the sale of its Zohydro ® ER ...
 Wall Street Business Network4 weeks ago Zogenix divests Zohydro ER business to Pernix  Bloomberg3 weeks ago Zogenix, Inc Closes Sale of Zohydro ER Business to Pernix  Reuters UK3 weeks ago Zogenix Closes Sale Of Zohydro ER Business To Pernix  BioSpace4 weeks ago

Pernix looks for a sales trifecta from 100 new Zohydro reps

Why buy a controversial pain drug franchise that's up against some hefty competition? Pernix Therapeutics ($PTX) has one word for you: synergies. With about two-thirds of chronic pain patients also reporting poor or unrefreshing sleep, the New ...
 FiercePharmaMarketing2 months ago Pernix figures 1 + 1 + 1 equals more than three with new Zohydro salesforce  FiercePharma2 months ago

Pernix Therapeutics announces encouraging results from chronic pain study

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, has announced encouraging results from a human pharmacokinetic equivalence study with ZX007, an abuse deterrent tablet formulation of hydrocodone bitartrate in patients with ...
 Individual.com2 days ago

Pernix Therapeutics announces availability of pain drug in US

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, has announced the availability of the new formulation of Zohydro extended-release, or ER, capsules, CII, with BeadTek, indicated for management of chronic pain, in the US. On ...
 Individual.com3 days ago

Zogenix Short Interest Down 5.1% in April (ZGNX)

Zogenix (NASDAQ:ZGNX) saw a significant decline in short interest in the month of April. As of April 30th, there was short interest totalling 25,353,712 shares, a decline of 5.1% from the April 15th total of 26,730,165 shares, AnalystRatings.Net ...
 American Banking News4 days ago Zogenix Sees Significant Decrease in Short Interest (ZGNX)  SleekMoney1 month ago

FDA approves pediatric version of Treximet to treat migraines

The FDA approved its first combination therapy to treat migraines in pediatric patients, giving its blessing to Pernix Therapeutics' ($PTX) Treximet for use in patients ages 12 to 17. Treximet was approved for adults in 2008, and the expanded ...
 Fierce Drug Delivery4 days ago

Brean Capital Reiterates Buy Rating for Zogenix (ZGNX)

Zogenix (NASDAQ:ZGNX) s stock had its buy rating reaffirmed by equities research analysts at Brean Capital in a research note issued to investors on Saturday. They currently have a $12.00 target price on the stock, up from their previous target ...
 SleekMoney5 days ago Zogenix Stock Rating Reaffirmed by Oppenheimer (ZGNX)  SleekMoney1 week ago Research Analysts Ratings Reiterations for May, 12th (ACT, NMRX, QNST, RAX, YY, ZGNX, ZSPH)  American Banking News - Forex1 week ago Zogenix Rating Reiterated by Oppenheimer (ZGNX)  American Banking News - Forex1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less